Headline News about Astrazeneca Plc ADR
Week In Review: Zenas Raises $259 Million In IPO
September 28, 2024
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
September 26, 2024
Via Benzinga
Exposures
Product Safety
AstraZeneca Options Trading: A Deep Dive into Market Sentiment
September 05, 2024
Via Benzinga
AstraZeneca's Asthma Drug Gets FDA Approval For Rare Disease Of Blood Vessel Inflammation
September 18, 2024
Via Benzinga
Exposures
Product Safety
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
September 10, 2024
Via Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
Via Benzinga
Via Benzinga
Exposures
Product Safety
10 Health Care Stocks Whale Activity In Today's Session
August 19, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free